APA (7th ed.) Citation

RA, J., A, T., JP, B., MW, P., RE, T., DJ, P., . . . R, P. (2026). Ames concordance with the in vivo transgenic rodent (TGR) gene mutation assay for NDSRIs and relative in vivo TGR potency with nitrosamines with robust dose-response carcinogenicity data. Regulatory toxicology and pharmacology : RTP, 167, 106051. https://doi.org/10.1016/j.yrtph.2026.106051

Chicago Style (17th ed.) Citation

RA, Jolly, et al. "Ames Concordance with the in Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative in Vivo TGR Potency with Nitrosamines with Robust Dose-response Carcinogenicity Data." Regulatory Toxicology and Pharmacology : RTP 167 (2026): 106051. https://doi.org/10.1016/j.yrtph.2026.106051.

MLA (9th ed.) Citation

RA, Jolly, et al. "Ames Concordance with the in Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative in Vivo TGR Potency with Nitrosamines with Robust Dose-response Carcinogenicity Data." Regulatory Toxicology and Pharmacology : RTP, vol. 167, 2026, p. 106051, https://doi.org/10.1016/j.yrtph.2026.106051.